BUB
VRTX icon

BBVA USA Bancshares’s Vertex Pharmaceuticals VRTX Stock Holding History

BBVA USA Bancshares’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,473
Closed -$270K – 503
2019
Q2 		$270K Sell
1,473
-639
-30% -$112K 0.02% 468
2019
Q1 		$388K Sell
2,112
-535
-20% -$98.8K 0.02% 398
2018
Q4 		$439K Sell
2,647
-295
-10% -$51.1K 0.03% 355
2018
Q3 		$567K Buy
2,942
+483
+20% +$86K 0.03% 367
2018
Q2 		$418K Sell
2,459
-83
-3% -$12.9K 0.03% 396
2018
Q1 		$414K Sell
2,542
-171
-6% -$27.9K 0.03% 399
2017
Q4 		$407K Sell
2,713
-517
-16% -$76.6K 0.03% 400
2017
Q3 		$491K Sell
3,230
-633
-16% -$95.3K 0.03% 367
2017
Q2 		$498K Buy
3,863
+385
+11% +$46.3K 0.03% 363
2017
Q1 		$380K Sell
3,478
-726
-17% -$63.9K 0.03% 408
2016
Q4 		$310K Sell
4,204
-430
-9% -$35K 0.02% 452
2016
Q3 		$404K Sell
4,634
-344
-7% -$32.5K 0.03% 393
2016
Q2 		$428K Sell
4,978
-613
-11% -$53K 0.03% 365
2016
Q1 		$444K Buy
5,591
+341
+6% +$30.8K 0.03% 369
2015
Q4 		$660K Buy
5,250
+866
+20% +$105K 0.05% 300
2015
Q3 		$457K Buy
4,384
+977
+29% +$126K 0.04% 332
2015
Q2 		$420K Buy
3,407
+622
+22% +$78.4K 0.02% 381
2015
Q1 		$328K Buy
2,785
+1,060
+61% +$127K 0.01% 463
2014
Q4 		$205K Buy
+1,725
New +$194K 0.01% 531

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BBVA USA Bancshares's VRTX Position: Q3 2019 in Review

BBVA USA Bancshares sold out of Vertex Pharmaceuticals (VRTX) in Q3 2019, closing a stake of 1,473 shares — an estimated $270K sold.

BBVA USA Bancshares first reported a position in VRTX in Q4 2014 and held it in 19 quarters. The position peaked at $660K in Q4 2015. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • BBVA USA Bancshares reported no remaining Vertex Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • BBVA USA Bancshares sold 1,473 Vertex Pharmaceuticals shares in Q3 2019, an estimated $270K.
  • BBVA USA Bancshares first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • BBVA USA Bancshares's Vertex Pharmaceuticals position peaked at $660K in Q4 2015.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on BBVA USA Bancshares's 13F filing for Q3 2019, filed 5 Nov 2019.